BNP Paribas — Income Investment
- Data cutoff: 2026-07-15, 14:12 CEST
- Security: BNP Paribas SA, Euronext Paris, ISIN
FR0000131104, EUR - Portfolio snapshot:
data/Portfolio-degiro-20260715.csv; CTO DEGIRO; tax residence France - Evidence quality: A- — current primary financial, prudential and dividend documents are available; 2Q26 results are not due until 2026-07-23, and DEGIRO withholding mechanics were not independently confirmed
- Purpose: learning and research, not investment advice
Classification convention: Verified fact comes from a cited source or the supplied portfolio; Estimate is a calculation from those facts; Assumption defines a scenario; Analytical judgment is the research conclusion.
1. Executive summary
Analytical judgment — HOLD – DO NOT ADD. BNP Paribas fits conviction + durable income better than opportunistic income: its diversified banking franchise, 50% minimum cash-dividend policy and regulatory-capital headroom support the distribution. It is not a yield trap. The constraint is allocation and price, not present dividend safety.
Verified fact. For 2025 BNP reported €10.29 EPS and paid €5.16 per share, a 50% cash payout. At 31 March 2026, CET1 was 12.8% against a 10.42% SREP requirement; 1Q26 net income rose 9.0% to €3.217bn, while cost of risk reached 39 bps, close to management's 2026 ceiling of below 40 bps.
Estimate. At the supplied €102.32 close, the trailing gross yield is 5.04%, PE is 9.94× and price/book is 0.98×. The three-share holding produces €15.48 annual gross income on the last declared annual dividend, or €10.62 under a simplified 2026 French PFU scenario of 31.4%. The latter is not a forecast of DEGIRO cash receipts.
Analytical judgment. The current price offers a fair dividend-led return but little margin of safety for bank, credit-cycle and litigation tail risk. The latest portfolio review already says no immediate trade; BNP is 3.43% of assets and total financial exposure is 21.38%. Reinforcement should wait for both a price at or below €90 and lower portfolio financial concentration.
2. Verdict and category
Verdict: HOLD – DO NOT ADD
- Possible role: existing 2–4% satellite/core-income bank position, not a stand-alone defensive bond substitute.
- Primary reason: earnings, capital and the stated payout policy presently cover a growing semiannual dividend.
- Primary risk: a credit/legal shock can consume capital and make a regulated bank's payout discretionary.
- Entry condition: study below €90, only if CET1 remains at least 12.5%, cost of risk remains at or below roughly 40–45 bps, and portfolio finance exposure falls to about 20% or less.
- Position-size range to study: 2–4% of portfolio value; 5% is a monitoring ceiling, not a universal recommendation.
- Reinforcement condition: price at or below €90 plus unchanged capital/distribution thesis and no adverse Sudan-litigation development.
- Reduction/exit criteria: CET1 below 11.5%, cost of risk above 60 bps for two reporting periods, dividend cut not caused solely by a system-wide temporary regulator ban, or weight above 5% without improved diversification.
- Monitoring: CET1, distance to MDA restrictions, cost of risk, impaired loans, 2026 interim dividend, legal provisions and Sudan appeal.
- Confidence: medium-high on current safety; medium on five-year growth because banks are cyclical and regulated.
Qualitative scorecard
| Dimension | Rating | Evidence |
|---|---|---|
| Business quality | Strong | Diversified European commercial banking, CIB, insurance and asset management |
| Cash-flow visibility | Adequate | Recurring spread and fee income, offset by credit and trading cyclicality |
| Dividend coverage | Strong | 2025 cash payout 50%; EPS coverage 1.99× |
| Balance-sheet strength | Strong | 12.8% CET1 vs 10.42% requirement; €18bn CET1 distance to MDA |
| Distribution history | Adequate | Five consecutive annual increases from 2020–2025, but 2019 distribution was suspended under the ECB pandemic recommendation |
| Dividend growth potential | Adequate | 8.89% 2021–2025 CAGR is unlikely to be a permanent run rate |
| Valuation | Adequate | 9.94× 2025 EPS and 0.98× book; current yield below the five-year year-end proxy |
| Cyclicality | Weak | Credit losses, rates, markets and regulation are macro-sensitive |
| Cut risk | Adequate | Low near term absent shock; meaningful in a severe recession or legal/capital event |
| Portfolio fit | Weak | Finance is already 21.38% of the supplied portfolio |
Blocking gates
| Gate | Result | Reason |
|---|---|---|
| Recurring uncovered distribution | Pass | 2025 dividend was covered 1.99× by EPS |
| Critical debt/refinancing risk | Pass | Capital, liquidity and regulatory funding headroom are adequate |
| Structural business deterioration | Pass | 1Q26 revenue and profit grew; no structural decline established |
| Insufficient fundamental data | Pass | Current primary disclosures available; 2Q26 is pending |
| Material governance/integrity concern | Pass with watch | Sudan litigation is material and unresolved, but current evidence does not establish a payout-blocking loss |
3. Possible portfolio role
Analytical judgment. BNP can provide EUR-denominated, growing bank income and exposure to a diversified European financial franchise. It is less suitable as a defensive income anchor because bank dividends depend on capital ratios, regulator consent, credit costs and market confidence.
Analytical judgment. The holding is conviction income rather than opportunistic yield: there is no short-term catalyst/exit structure, and the 5.04% trailing yield is not unusually high against BNP's own recent year-end yield proxy. The sensible role is a maintained small position, not a yield-driven trade.
4. Business and source of distributed cash
Verified fact. BNP earns net banking income from Commercial, Personal Banking & Services, Corporate & Institutional Banking, and Investment & Protection Services. 1Q26 net banking income was €14.056bn: CPBS €6.852bn, CIB €5.243bn and IPS €1.980bn before corporate-centre effects.
Analytical judgment. For a bank, free cash flow and net debt are misleading distribution measures. The relevant chain is recurring net income → retained earnings/CET1 generation → regulatory headroom → board/AGM distribution. Deposits and wholesale debt are operating funding, not industrial-company leverage.
Verified fact. BNP's 2026 distribution policy is 60% of earnings, with at least 50% in cash dividends and 10% in buybacks. Buybacks compete with retained capital but are the more flexible component; the dividend is the income component.
5. Dividend history and calendar
| Earnings year | Gross dividend/share | Change | Status |
|---|---|---|---|
| 2020 | €2.66 | — | Verified fact |
| 2021 | €3.67 | +38.0% | Verified fact |
| 2022 | €3.90 | +6.3% | Verified fact |
| 2023 | €4.60 | +17.9% | Verified fact |
| 2024 | €4.79 | +4.1% | Verified fact |
| 2025 | €5.16 | +7.7% | Verified fact; €2.59 interim plus €2.57 balance |
Estimate. The 2021–2025 dividend CAGR is 8.89% over four intervals. There were four increases, no holds, cuts or suspensions in that five-year window. The longer record is not unbroken: the dividend for 2019 was set to zero following the ECB's pandemic distribution recommendation.
Verified fact. BNP introduced semiannual payment from the 2025 financial year. The €2.59 interim was paid 30 September 2025; the €2.57 balance went ex-dividend 18 May 2026, record date 19 May and payment 20 May. The 2026 interim amount and exact dates were not declared by the cutoff; management describes payment around 30 September.
Analytical judgment. Waiting for an ex-dividend date is not a free gain: the share price theoretically adjusts by the cash distribution. Calendar timing must not justify buying a weak or overallocated position.
6. Distribution coverage and safety
| Measure | Latest | Assessment |
|---|---|---|
| 2025 EPS | €10.29 | Verified fact |
| 2025 dividend/share | €5.16 | Verified fact |
| Cash payout | 50.0% official | Verified fact |
| EPS coverage | 1.99× | Estimate |
| 1Q26 net income, group share | €3.217bn, +9.0% YoY | Verified fact |
| 1Q26 cost of risk | €922m / 39 bps | Verified fact; near management ceiling |
| 1Q26 RoTE | 12.8% | Verified fact |
Verified cross-check. The financial tool reconciled 1Q26 revenue at €14.056bn (BNP) versus €14.060bn (Reuters), a 0.01% deviation from the median; net income €3.217bn versus €3.220bn, a 0.05% deviation. BNP's €5.16 2025 dividend differs from StockAnalysis's €5.14 annualized figure by 0.19% from the median, within tolerance; issuer/AGM cash payments control.
Analytical judgment. Coverage is strong today. The leading warning is not the payout ratio but cost of risk: at 39 bps, it already sits at the edge of management's below-40-bps 2026 guidance. A worsening credit cycle can reduce earnings and capital simultaneously.
7. Balance sheet and refinancing
Verified fact. At 31 March 2026, CET1 was 12.8%, 238 bps above the 10.42% requirement. The leverage ratio was 4.4%, the liquidity coverage ratio 125%, HQLA €359bn and immediately available liquidity reserve €464bn.
Verified fact. BNP reported €18bn CET1 distance and €16bn minimum overall distance to Maximum Distributable Amount restrictions. Total capital was 17.3% versus a 14.60% requirement. These are buffers, not cash available to shareholders.
Verified fact. The 2026 regulatory issuance plan was €14bn; about 60% was completed by 1 May 2026. Wholesale medium/long-term funding outstanding was €264bn, with economic maturities spread across years. BNP showed €13bn of senior non-preferred maturities in 2026, €11bn in 2027 and €11bn in 2028.
Analytical judgment. Refinancing is manageable in the base case. A market-access freeze would still be material because BNP is a leveraged G-SIB; liquidity reserves and loss-absorbing debt reduce, but do not eliminate, that tail risk.
8. Income growth
Verified fact. Dividend/share rose from €3.67 in 2021 to €5.16 in 2025 while 2025 EPS increased to €10.29. 1Q26 revenue growth of 8.5% and net-income growth of 9.0% support near-term distributable-earnings momentum.
Analytical judgment. A normalized 3–6% dividend growth range is more prudent than extrapolating the 8.89% historical CAGR. Capital requirements, credit losses, share count, legal costs and the split between dividends and buybacks will determine actual growth.
Verified fact. A €219m 1Q26 provision for UK motor-finance legal risk reduced group net income by €98m after tax and minorities. This illustrates why accounting/legal charges can interrupt a smooth dividend-growth path even when underlying operations improve.
9. Valuation and margin of safety
| Metric at €102.32 | Result | Status |
|---|---|---|
| PE on 2025 EPS | 9.94× | Exact estimate |
| Earnings yield | 10.06% | Exact estimate |
| Price / 2025 net book value | 0.98× | Exact estimate |
| Trailing dividend yield | 5.04% | Exact estimate |
| DEGIRO P/E field | 7.64× | Supplied fact; not used because its earnings denominator is undocumented |
Estimate. A simple year-end indicated-yield proxy using issuer year-end prices and the corresponding dividends for 2021–2025 averages 7.04%. It is not a time-weighted historical yield. Today's 5.04% is below that proxy, showing that the stock has rerated rather than offering exceptional income value.
Analytical judgment. Appropriate bank valuation anchors are PE, price/book, sustainable RoTE and capital—not FCF yield. A reasonable current intrinsic range is €90–€115. The supplied price is 12.0% above the lower bound and offers only 12.4% upside to the upper bound before dividends: adequate for holding, thin for adding.
Estimate. At €90, the trailing yield would be 5.73%; at €85, 6.07%. Those levels better compensate for cyclicality and the unresolved litigation tail.
10. Tax and currency
Verified fact. The share and distributions are denominated in EUR, matching the portfolio's reference currency. BNP's underlying earnings remain exposed to GBP, USD and other currencies through international operations.
Verified fact. France's official 2026 guidance states that the default PFU for dividends comprises 12.8% income tax plus 18.6% social levies, or 31.4% in total. A progressive-scale election is global across relevant investment income and may permit a 40% dividend allowance; its benefit depends on the taxpayer's full situation.
| Holding calculation | Gross | Simplified PFU scenario |
|---|---|---|
| 3 shares × €5.16 | €15.48/year | €10.62/year after 31.4% |
| Per semiannual payment | Not calculable prospectively | Not calculable prospectively |
Assumption. The €10.62 scenario assumes a French-resident individual, ordinary CTO, default PFU, no exemption and full application of the 2026 rates.
Data gap. DEGIRO's actual French advance withholding, social-levy collection and declaration timing were not confirmed. The issuer's own tax page still displayed the older 17.2% social rate at the cutoff, while Service Public had been updated to 18.6%. Therefore €10.62 is a tax scenario, not confirmed cash income; professional tax advice may be needed.
11. Portfolio fit
| Item | Result | Status |
|---|---|---|
| Quantity | 3 shares | Supplied fact |
| Position value | €306.96 | Supplied fact |
| Cost basis | €64.55/share | Supplied fact |
| Portfolio weight | 3.43% | Supplied/verified portfolio report |
| Total financial exposure | 21.38% | Verified portfolio report |
| Gross yield on cost | 7.99% | Exact estimate; retrospective only |
| Annual gross income at last DPS | €15.48 | Exact estimate |
| Contribution to portfolio value as gross income | 0.173% / 17.3 bps | Exact estimate |
Analytical judgment. Company quality and allocation fit diverge: BNP itself merits conviction-income status, but the portfolio already holds Crédit Agricole, Bank of America and T. Rowe Price. Adding would deepen correlated exposure to credit, rates and financial-market stress. The current 3.43% weight is reasonable; total finance concentration blocks reinforcement.
Data gap. Contribution to total portfolio dividend income is not calculable because verified forward distributions for every holding were not provided. No proposed trade quantity was supplied, so after-trade weight and income are not calculable.
Expected gross income by month
| Month | Confirmed/expected BNP gross income for current 3 shares |
|---|---|
| May 2026 | €7.71 only if the shares were held through the record date; the July snapshot does not prove that |
| Around September 2026 | Unknown; 2026 interim not declared at cutoff |
| Other months | €0 under the stated semiannual policy |
12. Scenarios: base, adverse, severe
These are stress tests, not forecasts. Values use exact arithmetic and exclude any separate value assigned to buybacks.
| Case | Operating and distributable-earnings assumptions | Coverage/capital | Dividend outcome | Valuation implication |
|---|---|---|---|---|
| Base | Assumption: 2026 EPS €10.90; cost of risk ≤40–45 bps; AXA IM integration broadly on plan | Estimate: 50% cash payout; CET1 12.8–13.0%; coverage 2.0× | Estimate: €5.45/share, +5.6% | Estimate: 9–10× EPS = €98.10–€109.00 |
| Adverse | Assumption: EPS 25% below 2025 at €7.72; cost of risk ~60 bps; weaker CIB/retail fees | Estimate: CET1 11.8–12.2%; refinancing cost rises; 50% payout | Estimate: €3.86/share, a 25% cut | Estimate: 7–8× = €54.02–€61.74 |
| Severe | Assumption: EPS 50% below 2025 at €5.15; cost of risk >100 bps; major legal/credit loss and market-access stress | Estimate: CET1 approaches regulatory buffers; payout retained at 40% or regulator limits distributions | Estimate: €2.06/share, a 60% cut | Estimate: 5–7× = €25.72–€36.02 |
Analytical judgment. The base case supports the dividend but offers modest price upside. The adverse and severe cases show why a 5% yield cannot be treated as bond-like: price loss and dividend cuts can occur together.
13. Dividend-cut risks
| Risk | Transmission to dividend | Current signal |
|---|---|---|
| European credit recession | Higher provisions reduce earnings and CET1 | Cost of risk already 39 bps; watch closely |
| Capital/regulatory intervention | ECB can restrict distributions; MDA buffer can shrink | Current headroom strong |
| Sudan litigation | Settlement/judgment could consume earnings/capital and damage confidence | Appeal pending; tail amount unresolved |
| UK motor finance | Further provisions reduce distributable earnings | €219m provision in 1Q26 |
| CIB/market volatility | Trading and advisory earnings can fall | 1Q26 CIB revenue -0.8% reported, +3.1% constant scope/FX |
| Funding/liquidity shock | Higher spreads and deposit competition compress earnings | Current LCR 125%; issuance progressing |
| Political taxation | Bank levies or windfall taxes reduce capital generation | Persistent European sector risk |
Verified fact. A U.S. jury awarded about $21m to three Sudanese plaintiffs in October 2025. BNP filed its opening appeal brief on 22 May 2026; the potential broader class effect remains contested and unquantified. Analytical judgment: this is the main low-probability/high-impact integrity and dividend tail risk.
14. Purchase or reinforcement conditions
Analytical judgment. Do not add now. Reconsider only when all of the following hold:
- price at or below €90, preferably below €85 for a strong margin of safety;
- CET1 at least 12.5% and clear progress toward 13% in 2027;
- cost of risk no worse than 40–45 bps and no sharp impaired-loan acceleration;
- confirmed interim dividend consistent with at least a 50% cash payout;
- no material adverse Sudan judgment/settlement or unreserved legal charge;
- portfolio finance exposure about 20% or less after the trade.
Analytical judgment. Do not buy merely before an ex-dividend date. The price adjustment and 31.4% PFU baseline eliminate any mechanical income advantage.
15. Reduction or sale conditions
Analytical judgment. Study reduction if any one fundamental condition becomes persistent: CET1 below 11.5%; cost of risk above 60 bps for two periods; capital distribution suspended for bank-specific reasons; an inadequately reserved legal loss that threatens the 2027 capital target; or a structural fall in RoTE below the cost of equity.
Analytical judgment. Study valuation-led trimming above €125 unless sustainable RoTE rises above roughly 11–12% and dividend growth justifies the rerating. Also trim/rebalance if BNP exceeds 5% or finance exposure rises materially above the current 21.38%.
Analytical judgment. Yield on cost of 7.99% is not a hold reason. The decision must use current value, forward income and alternative uses of capital.
16. Monitoring table
| Indicator | Latest / next event | Green | Warning | Action trigger |
|---|---|---|---|---|
| CET1 | 12.8% at 2026-03-31 | ≥12.5% | 11.5–12.5% | <11.5% |
| SREP CET1 requirement | 10.42% | Buffer >200 bps | 100–200 bps | <100 bps |
| Cost of risk | 39 bps 1Q26 | ≤40 bps | 40–60 bps | >60 bps twice |
| Net income | €3.217bn 1Q26 | Positive YoY growth | Flat/down modestly | >25% normalized decline |
| Cash payout | ≥50% policy | ≥50% with stable CET1 | <50% explained | Cut/suspension bank-specific |
| 2026 interim dividend | Not declared | Consistent with 50% H1 EPS | Material shortfall | Cancellation |
| LCR | 125% | ≥120% | 110–120% | Near 100% |
| Sudan litigation | Appeal pending | Reversal/contained settlement | Uncertain class expansion | Capital-threatening judgment |
| Portfolio finance weight | 21.38% | ≤20% | 20–25% | >25% |
| Next results | 2Q26 on 2026-07-23 | — | — | Refresh report after release |
17. One-sentence conclusion
HOLD – DO NOT ADD: BNP Paribas currently offers covered, growing conviction income, but a 5.04% yield at fair value does not compensate enough to increase an already finance-heavy portfolio before 2Q26 results and clearer litigation/tax-withholding evidence.
18. Sources and data quality
Evidence quality is A-. Decision-critical 1Q26 revenue and net income were cross-checked against Reuters within 0.1%; dividend/share was checked against StockAnalysis within 1%, with the issuer's approved cash amounts controlling. Portfolio facts come from the supplied file and its same-day audited portfolio review. The material gaps are 2Q26 (scheduled after the cutoff), the undeclared 2026 interim dividend, the unquantified Sudan tail and DEGIRO's exact withholding workflow.
| Source title | Issuer/publisher | Publication date | Accessed | Reporting period | Type | URL |
|---|---|---|---|---|---|---|
| First Quarter 2026 Results | BNP Paribas | 2026-04-30 | 2026-07-15 | 1Q26 | Primary | https://invest.bnpparibas/document/1q26-pr |
| Debt Investors Presentation — May 2026 | BNP Paribas | 2026-05-13 | 2026-07-15 | 2026-03-31 / May 2026 | Primary | https://invest.bnpparibas/document/debt-investors-presentation-roadshow-13-15-may-2026 |
| 2025 Universal Registration Document and Annual Financial Report | BNP Paribas | 2026-03-13 | 2026-07-15 | FY2025 | Primary | https://invest.bnpparibas/en/document/universal-registration-document-annual-financial-report-2025-pdf |
| 2026 AGM Convening Notice | BNP Paribas | 2026-03-13 | 2026-07-15 | FY2025 dividend | Primary | https://invest.bnpparibas/en/document/agm-2026-convening-notice |
| BNP Paribas share — dividend history | BNP Paribas | Continuously updated | 2026-07-15 | 1998–2025 | Primary | https://invest.bnpparibas/en/bnp-paribas-share |
| Sudan Litigation: Statement from BNP Paribas | BNP Paribas | 2026-06-01 | 2026-07-15 | Appeal status | Primary, interested party | https://invest.bnpparibas/en/document/sudan-litigation-statement-from-bnp-paribas |
| BNP Paribas reports 9% rise in Q1 profit | Reuters, republished by LSE.co.uk | 2026-04-30 | 2026-07-15 | 1Q26 | Secondary, independent | https://www.lse.co.uk/news/bnp-paribas-reports-9-rise-in-q1-profit-investment-bank-stutters-b0k26rdtztkf2of.html |
| US jury issues $20M verdict against BNP Paribas | Associated Press | 2025-10-18 | 2026-07-15 | Sudan trial verdict | Secondary, independent | https://apnews.com/article/7bacbbb049bc79e1dfa805a02e06bd3c |
| BNP Paribas dividend history | StockAnalysis | 2026-06 | 2026-07-15 | 2025/2026 annualized | Secondary, independent | https://stockanalysis.com/quote/epa/BNP/dividend/ |
| Impôt sur le revenu — revenus d'épargne et de placement — revenus 2026 | Service Public / DILA | 2026-04-15 | 2026-07-15 | Tax year 2026 | Primary official guidance | https://www.service-public.gouv.fr/particuliers/vosdroits/F34913/1_7?lang=fr |
| BNP PARIBAS, FR0000131104 | Euronext | Continuously updated | 2026-07-15 | Market/corporate actions | Primary exchange | https://live.euronext.com/fr/product/equities/FR0000131104-MTAH |
| Revue du portefeuille — CTO DEGIRO | AI Berkshire / supplied data | 2026-07-15 | 2026-07-15 | Portfolio snapshot 2026-07-15 | Internal primary input | reports/portfolio-degiro-20260715.md |
Calculation log
tools/financial_rigor.py verified PE 9.94×, earnings yield 10.06%, P/B 0.98×, ROE 9.87% and yield 5.04%. Exact calculations covered gross/net income, yield on cost, portfolio contribution, dividend CAGR, historical-yield proxy, entry yields and all three scenarios. Cross-validation found no decision-critical discrepancy above 1%; StockAnalysis's €5.14 is an annualized data-vendor figure, while BNP's €5.16 equals the two approved cash payments and is retained.